HUATAI-PINEBRIDGE FUND MANAGEMENT HANG SENG INNOVATIVE DRUG ETF CNY

An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.

520500 trades at 1.348 CNY today, its price has fallen −1.02% in the past 24 hours. Track more dynamics on 520500 price chart.

520500 net asset value is 1.37 today — it's risen 13.66% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.

520500 price has risen by 9.63% over the last month, and its yearly performance shows a 33.73% increase. See more dynamics on 520500 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 13.66% over the last month, showed a 22.43% increase in three-month performance and has increased by 38.50% in a year.

Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.

520500 expense ratio is 0.60%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.

No, 520500 doesn't pay dividends to its holders.

520500 trades at a premium (0.14%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.

520500 shares are issued by Huatai-PineBridge Fund Management Co., Ltd.

520500 follows the Hang Seng Innovative Drug Index yield - HKD - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

The fund started trading on Dec 16, 2024.